Company Filing History:
Years Active: 2009
Title: Helmut Fritsch: Innovator in Pharmaceutical Chemistry
Introduction
Helmut Fritsch is a notable inventor based in Lörrach, Germany. He has made significant contributions to the field of pharmaceutical chemistry, particularly in the synthesis of complex organic compounds. His work has implications for the development of essential vitamins, including pyridoxine, a well-known form of vitamin B.
Latest Patents
Helmut Fritsch holds a patent for a process that involves the manufacturing of 3-unsubstituted, 3-monosubstituted, or 3,3-disubstituted 9-acyloxy-1,5-dihydro-8-methylpyrido[3,4-e][1,3]dioxepin. This innovative process includes performing an addition reaction between a 4-methyl-5-alkoxy-oxazole and a 2-unsubstituted, 2-monosubstituted, or 2,2-disubstituted 4,7-dihydro-(1,3)-dioxepin in the absence of a solvent and catalyst. The method results in a product mixture that can be further processed to produce pyridoxine through acid hydrolysis.
Career Highlights
Helmut Fritsch is associated with Dsm IP Assets B.V., where he has been instrumental in advancing research and development in pharmaceutical applications. His expertise in organic synthesis has led to innovative solutions that enhance the efficacy of vitamin formulations.
Collaborations
Helmut has collaborated with notable colleagues such as Jocelyn Fischesser and Andrew George Gum. Their combined efforts have contributed to the successful development of new chemical processes and products.
Conclusion
Helmut Fritsch's work exemplifies the intersection of innovation and practical application in the pharmaceutical industry. His contributions to the synthesis of vital compounds like pyridoxine highlight the importance of research in improving health outcomes.